Stock listing
NAUT Stock Price, News, Filings & Events — Nautilus Biotechnology, Inc.
Selected listing: NAUT · NASDAQ · USD · US
This page tracks Nautilus Biotechnology, Inc.'s NAUT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NAUT:NASDAQ. NAUT:NASDAQ is the stock-level entry point for investors researching Nautilus Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nautilus Biotechnology, Inc. is a public company traded under the ticker NAUT in the American market. The company has a market capitalization of approximately $214.76 million. Nautilus focuses on advancing biotechnology solutions, contributing to the development of innovative approaches in the field.
- Ticker
- NAUT:NASDAQ
- Asset type
- Stock
- Market cap
- $114.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Nautilus Biotechnology, Inc. NAUT:NASDAQ stock context
This page tracks Nautilus Biotechnology, Inc.'s NAUT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NAUT:NASDAQ. NAUT:NASDAQ is the stock-level entry point for investors researching Nautilus Biotechnology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nautilus Biotechnology, Inc. is a public company traded under the ticker NAUT in the American market. The company has a market capitalization of approximately $214.76 million. Nautilus focuses on advancing biotechnology solutions, contributing to the development of innovative approaches in the field.
Latest news from Nautilus Biotechnology, Inc.
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
July 28, 2026
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
July 8, 2026
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
April 28, 2026
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
April 9, 2026
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
March 24, 2026
Nautilus Biotechnology, Inc. earnings calls
Nautilus Biotechnology, Inc. (NAUT) Q2 2026 Earnings Call
July 28, 2026 · Replay with transcript and chapters
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call
April 28, 2026 · Replay with transcript and chapters
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Nautilus Biotechnology, Inc. (NAUT) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
Nautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Call
July 31, 2025 · Replay with transcript and chapters
Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call
April 29, 2025 · Replay with transcript and chapters
Research Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. investor report
Review AI stock analysis and investor report context for NAUT:NASDAQ.
Nautilus Biotechnology, Inc. company profile
View the public company page for Nautilus Biotechnology, Inc. on 6ix.
Nautilus Biotechnology, Inc. news
Read company news and market updates connected to Nautilus Biotechnology, Inc..
Nautilus Biotechnology, Inc. investor events
Find investor webinars, events, and replay context for Nautilus Biotechnology, Inc..